Several vaccines against COVID-19 use nanoparticles to protect the antigen cargo (either
proteins or nucleic acids), increase the immunogenicity and ultimately the efficacy. The …

The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
highlighted the need for vaccines that not only prevent disease but also prevent …

Vaccines play a critical role in combating the COVID-19 pandemic. Future control of the
pandemic requires improved vaccines with high efficacy against newly emerging SARS-CoV …

Background Chlamydia is the most common sexually transmitted bacterial infection
worldwide. National screening programmes and antibiotic treatment have failed to decrease …

The human immune system and the microbiota co-evolve, and their balanced relationship is
based on crosstalk between the two systems through the course of life. This tight association …

Adjuvants contribute to enhancing and shaping the vaccine immune response through
different modes of action. Here early biomarkers of adjuvanticity after primary immunization …

Global vaccination strategies have traditionally relied on the hypodermic needle and syringe
model. However, to facilitate increased immunization coverage and reduce costs, novel …

Peptide-based T cell vaccines targeting the conserved epitopes of influenza virus can
provide cross-protection against distantly related strains, but they are generally not …

Background Administered intramuscularly (IM), plant-derived, virus-like-particle (VLP)
vaccines based on the influenza hemagglutinin (HA) protein elicit both humoral and cellular …